Insulin Pump Therapy and Adverse Skin Reactions With Focus on Allergic Contact Dermatitis in Individuals Living With Diabetes Mellitus: A Systematic Review and Clinical-Based Update

Overview

Journal J Diabetes Sci Technol

Specialty Endocrinology

Date 2024 Jun 10

PMID 38853748

Authors

Laura Beate von Kobyletzki

Josefin Ulriksdotter

Elisa von Kobyletzki

Martin Mowitz

Johan Jendle

Cecilia Svedman

Affiliations

Soon will be listed here.

Abstract

Background: The use of insulin pumps (continuous subcutaneous insulin infusion [CSII]) in individuals living with type 1 diabetes (T1D) improves disease control. However, adverse skin reactions may hamper compliance. We aimed to assess the relationship of insulin pumps, particularly that of infusion set therapy, used in children and adults with T1D and dermatitis including allergic contact dermatitis (ACD).

Methods: A systematic search of PubMed, and EMBASE, of full-text studies reporting dermatitis in persons with diabetes using a CSII was conducted from 2020 to 2023. The Newcastle-Ottawa Scale was used to assess study quality. The inventory performed at the Department of Occupational and Environmental Dermatology, Malmö, Sweden (YMDA) was also performed highlighting the diagnostic process.

Results: Among the 391 screened abstracts, 21 studies fulfilled the inclusion criteria. Seven studies included data on children only, four studies were on adults, and nine studies reported data on both children and adults. Participants were exposed to a broad range of pumps. Dermatitis was rarely specified. Up to 60% of those referred to a university hospital due to skin reactions possibly related to insulin pumps had an ACD.

Conclusions: The review and our findings indicate that there is not sufficient focus on contact allergy in the primary toxicological evaluations of substances used also for insulin pump therapy products and that possible adverse skin reactions are not correctly followed up in the clinical setting.

References

Jendle J, Reznik Y . Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers. Diabetes Obes Metab. 2023; 25 Suppl 2:21-32. DOI: 10.1111/dom.15087. View

Persad S, Lejding T, Svedman C, Mowitz M . The missing link: Allergic contact dermatitis caused by 1,6-hexanediol diacrylate in a glucose sensor transmitter. Contact Dermatitis. 2023; 89(4):303-305. DOI: 10.1111/cod.14385. View

Weng A, Zachariae C, Christensen K, Svensson J, Berg A . Five-Month Follow-up Shows No Improvement in Dermatological Complications in Children With Type 1 Diabetes Using Continuous Glucose Monitoring Systems and Insulin Pumps. J Diabetes Sci Technol. 2019; 15(2):317-323. PMC: 8256062. DOI: 10.1177/1932296819882425. View

Cichon M, Mysliwiec M, Trzeciak M . Role of acrylates in the development of contact dermatitis in diabetic patients-A Polish dermatology tertiary centre experience. Contact Dermatitis. 2023; 90(2):126-133. DOI: 10.1111/cod.14436. View

Berg A, Norgaard K, Thyssen J, Zachariae C, Hommel E, Rytter K . Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study. Diabetes Technol Ther. 2018; 20(7):475-482. DOI: 10.1089/dia.2018.0088. View

Rigo R, Levin L, Belsito D, Garzon M, Gandica R, Williams K . Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus. J Diabetes Sci Technol. 2020; 15(4):786-791. PMC: 8258506. DOI: 10.1177/1932296820918894. View

Demir G, Er E, Atik Altinok Y, Ozen S, Darcan S, Goksen D . Local complications of insulin administration sites and effect on diabetes management. J Clin Nurs. 2021; 31(17-18):2530-2538. DOI: 10.1111/jocn.16071. View

Messer L, Berget C, Beatson C, Polsky S, Forlenza G . Preserving Skin Integrity with Chronic Device Use in Diabetes. Diabetes Technol Ther. 2018; 20(S2):S254-S264. PMC: 6011799. DOI: 10.1089/dia.2018.0080. View

Diedisheim M, Pecquet C, Julla J, Carlier A, Potier L, Hartemann A . Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study. Diabetes Technol Ther. 2023; 25(4):279-286. DOI: 10.1089/dia.2022.0513. View

10.

Lombardo F, Passanisi S, Tinti D, Messina M, Salzano G, Rabbone I . High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey. J Diabetes Sci Technol. 2020; 15(6):1377-1381. PMC: 8655296. DOI: 10.1177/1932296820947072. View

11.

Geneve P, Adam T, Delawoevre A, Jellimann S, Legagneur C, DiPatrizio M . High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes. Diabetes Res Clin Pract. 2023; 204:110922. DOI: 10.1016/j.diabres.2023.110922. View

12.

Lombardo F, Salzano G, Crisafulli G, Panasiti I, Alibrandi A, Messina M . Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue. Diabetes Res Clin Pract. 2020; 162:108089. DOI: 10.1016/j.diabres.2020.108089. View

13.

Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R . Insulin pump therapy: a meta-analysis. Diabetes Care. 2003; 26(4):1079-87. DOI: 10.2337/diacare.26.4.1079. View

14.

Ulriksdotter J, Mowitz M, Svedman C, Bruze M . Patch testing and diagnosis when suspecting allergic contact dermatitis from medical devices. Contact Dermatitis. 2020; 83(4):333-335. DOI: 10.1111/cod.13650. View

15.

Lombardo F, Passanisi S, Caminiti L, Barbalace A, Marino A, Iannelli M . High Prevalence of Skin Reactions Among Pediatric Patients with Type 1 Diabetes Using New Technologies: The Alarming Role of Colophonium. Diabetes Technol Ther. 2019; 22(1):53-56. DOI: 10.1089/dia.2019.0236. View

16.

Johansen J, Aalto-Korte K, Agner T, Andersen K, Bircher A, Bruze M . European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis. 2015; 73(4):195-221. DOI: 10.1111/cod.12432. View

17.

Berg A, Thorsen S, Thyssen J, Zachariae C, Keiding H, Svensson J . Cost of Treating Skin Problems in Patients with Diabetes Who Use Insulin Pumps and/or Glucose Sensors. Diabetes Technol Ther. 2019; 22(9):658-665. DOI: 10.1089/dia.2019.0368. View

18.

Burnside M, Lewis D, Crocket H, Meier R, Williman J, Sanders O . Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial. Diabetes Technol Ther. 2023; 25(4):250-259. DOI: 10.1089/dia.2022.0484. View

19.

Berg A, Grauslund A, Sorensen F, Thorsen S, Thyssen J, Zachariae C . A Skin Care Program to Prevent Skin Problems due to Diabetes Devices in Children and Adolescents: A Cluster-Controlled Intervention Study. Diabetes Care. 2023; 46(10):1770-1777. DOI: 10.2337/dc23-0462. View

20.

Ulriksdotter J, Sukakul T, Bruze M, Mowitz M, Ofenloch R, Svedman C . Contact Allergy to Allergens in the Swedish Baseline Series Overrepresented in Diabetes Patients with Skin Reactions to Medical Devices - A Retrospective Study from Southern Sweden. Acta Derm Venereol. 2024; 104:adv19676. PMC: 11000652. DOI: 10.2340/actadv.v104.19676. View